Invasive mucinous adenocarcinoma (IMA) is a relatively rare subtype of lung
adenocarcinoma, composed of goblet and/or columnar tumour cells containing abundant …

With the widespread implementation of lung cancer screening, more and more patients are
being diagnosed with multiple primary lung cancers (MPLCs). In the era of precision …

Background Diagnosing and treating patients with multiple primary lung cancers (MPLCs)
bring challenges to the clinic, and the preliminary evidence has revealed unsatisfying …

Purpose: In patients with> 1 non–small cell lung carcinoma (NSCLC), the distinction
between separate primary lung carcinomas (SPLCs) and intrapulmonary metastases (IPMs) …

Introduction Pulmonary invasive mucinous adenocarcinomas (IMAs) often present with
spatially separate lung lesions. Clonal relationship between such lesions, particularly those …

Introduction Morphologic and molecular data for staging of multifocal lung squamous cell
carcinomas (LSCCs) are limited. In this study, whole exome sequencing (WES) was used as …

Background We evaluated the long-term prognosis of synchronous multiple primary lung
cancer (SMPLC) patients after surgical treatment and explored prognostic factors for overall …

The distinction between different separate primary lung cancers (SPLCs) and
intrapulmonary metastases (IPMs) is a challenging but clinically significant issue …

Introduction The distinction between multiple primary lung cancer (MPLC) and
intrapulmonary metastasis (IPM) holds clinical significance in staging, therapeutic …

Objective The incidence of early stage multiple primary lung cancer (MPLC) has been
increasing in recent years, while the ideal strategy for its diagnosis and treatment remains …